The protective effects of thalidomide derivative ZSN-12 on acute lung injury

高小力,孟祥豹,蒋益民,李中军,叶加
DOI: https://doi.org/10.5246/jcps.2013.05.064
2013-01-01
Abstract:The aim of this study was to evaluate the protective effect of thalidomide derivative ZSN-12 on acute lung injury induced by oleic acid in mice,and to investigate the possible mechanisms.The results showed that ZSN-12(200 mg/kg) markedly improved the pathological changes of acute lung injury.The proportion of polymorphonuclear neutrophils(PMN) was reduced by 48%(P<0.01) and the content of nitric oxide(NO) in bronchoalveolar lavage fluid(BALF) was decreased by 33%(P<0.05).ZSN-12 produced significant anti-inflammatory effects in the models of xylene induced ear edema and carrageenan induced paw edema,in which ZSN-12 inhibited ear edema and paw swelling in a dose-dependent manner.The inhibition rates by ZSN-12 dosed at 200,100,50 mg/kg were 62%,43%,and 30% in ear edema,respectively and 60%,47%,and 33% in paw edema,respectively,at 3 h.Meanwhile,ZSN-12(10,5,1 μmol/L) significantly restrained the ConA-induced T lymphocyte proliferation,with the inhibition rates of 33%,30% and 22%,respectively(P<0.01).In conclusion,the present study showed that administration of thalidomide derivative ZSN-12 exerted significant protective effect in acute lung injury induced by oleic acid in mice,which may be related to its anti-inflammation effect.ZSN-12 inhibited the effusion of PMN,reduced the release of NO,and suppressed the proliferation of T lymphocyte.
What problem does this paper attempt to address?